Robert Driscoll
Stock Analyst at Wedbush
(4.57)
# 1,044
Out of 4,693 analysts
372
Total ratings
46.7%
Success rate
12%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert Driscoll
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVMD Revolution Medicines | Maintained: Buy | $201 → $225 | $207.90 | +8.23% | 26 | Aug 27, 2026 | |
| IDYA IDEAYA Biosciences | Maintained: Buy | $60 | $39.86 | +50.53% | 27 | Aug 20, 2026 | |
| REPL Replimune Group | Reiterated: Buy | $19 | $15.92 | +19.35% | 22 | Aug 17, 2026 | |
| PYXS Pyxis Oncology | Reiterated: Buy | $6 | $3.68 | +63.04% | 3 | Aug 14, 2026 | |
| TNGX Tango Therapeutics | Reiterated: Buy | $33 → $39 | $22.44 | +73.80% | 12 | Aug 12, 2026 | |
| ACET Adicet Bio | Reiterated: Buy | $25 | $9.21 | +171.44% | 11 | Aug 6, 2026 | |
| RCUS Arcus Biosciences | Reiterated: Buy | $41 → $43 | $29.55 | +45.52% | 25 | Aug 6, 2026 | |
| BDTX Black Diamond Therapeutics | Reiterated: Buy | $14 | $2.13 | +558.82% | 15 | Aug 6, 2026 | |
| ARVN Arvinas | Maintained: Hold | $11 → $12 | $9.48 | +26.65% | 27 | Aug 5, 2026 | |
| TYRA Tyra Biosciences | Maintained: Buy | $53 | $25.09 | +111.24% | 16 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 → $27 | $14.10 | +91.49% | 11 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 | $18.69 | +44.50% | 6 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 | $22.10 | +67.46% | 19 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 | $12.87 | +179.72% | 31 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $5.10 | +96.15% | 15 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $3.74 | +194.51% | 18 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 → $30 | $11.33 | +164.78% | 6 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $74.70 | +7.10% | 4 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 → $34 | $19.32 | +75.98% | 4 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $6 | $0.7986 | +651.31% | 8 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $7 → $5 | $11.16 | -55.20% | 3 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $36 | $19.48 | +84.80% | 12 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6 → $1 | $0.96895 | +3.20% | 4 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 | $3.75 | n/a | 13 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 | $6.40 | n/a | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $6 | $1.58 | n/a | 14 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $2.41 | n/a | 4 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $67 | $149.71 | n/a | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $6 | $5.12 | n/a | 8 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $14.15 | n/a | 4 | Oct 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $7 → $10 | $0.0001 | n/a | 2 | Mar 19, 2020 |
Revolution Medicines
Aug 27, 2026
Maintained: Buy
Price Target: $201 → $225
Current: $207.90
Upside: +8.23%
IDEAYA Biosciences
Aug 20, 2026
Maintained: Buy
Price Target: $60
Current: $39.86
Upside: +50.53%
Replimune Group
Aug 17, 2026
Reiterated: Buy
Price Target: $19
Current: $15.92
Upside: +19.35%
Pyxis Oncology
Aug 14, 2026
Reiterated: Buy
Price Target: $6
Current: $3.68
Upside: +63.04%
Tango Therapeutics
Aug 12, 2026
Reiterated: Buy
Price Target: $33 → $39
Current: $22.44
Upside: +73.80%
Adicet Bio
Aug 6, 2026
Reiterated: Buy
Price Target: $25
Current: $9.21
Upside: +171.44%
Arcus Biosciences
Aug 6, 2026
Reiterated: Buy
Price Target: $41 → $43
Current: $29.55
Upside: +45.52%
Black Diamond Therapeutics
Aug 6, 2026
Reiterated: Buy
Price Target: $14
Current: $2.13
Upside: +558.82%
Arvinas
Aug 5, 2026
Maintained: Hold
Price Target: $11 → $12
Current: $9.48
Upside: +26.65%
Tyra Biosciences
Aug 5, 2026
Maintained: Buy
Price Target: $53
Current: $25.09
Upside: +111.24%
Aug 3, 2026
Maintained: Buy
Price Target: $37 → $27
Current: $14.10
Upside: +91.49%
Jul 31, 2026
Maintained: Buy
Price Target: $27
Current: $18.69
Upside: +44.50%
Jul 29, 2026
Reiterated: Buy
Price Target: $37
Current: $22.10
Upside: +67.46%
Jul 28, 2026
Maintained: Buy
Price Target: $36
Current: $12.87
Upside: +179.72%
Jul 20, 2026
Maintained: Buy
Price Target: $10
Current: $5.10
Upside: +96.15%
Jun 4, 2026
Reiterated: Buy
Price Target: $11
Current: $3.74
Upside: +194.51%
May 27, 2026
Reiterated: Buy
Price Target: $38 → $30
Current: $11.33
Upside: +164.78%
May 18, 2026
Reiterated: Buy
Price Target: $80
Current: $74.70
Upside: +7.10%
May 14, 2026
Reiterated: Buy
Price Target: $29 → $34
Current: $19.32
Upside: +75.98%
May 14, 2026
Reiterated: Buy
Price Target: $7 → $6
Current: $0.7986
Upside: +651.31%
May 12, 2026
Maintained: Sell
Price Target: $7 → $5
Current: $11.16
Upside: -55.20%
May 8, 2026
Reiterated: Buy
Price Target: $45 → $36
Current: $19.48
Upside: +84.80%
Dec 19, 2025
Downgraded: Hold
Price Target: $6 → $1
Current: $0.96895
Upside: +3.20%
Aug 7, 2025
Maintained: Hold
Price Target: $4
Current: $3.75
Upside: n/a
Jul 14, 2025
Initiated Coverage: Buy
Price Target: $27
Current: $6.40
Upside: n/a
May 8, 2025
Maintained: Buy
Price Target: $7 → $6
Current: $1.58
Upside: n/a
Aug 14, 2024
Reiterated: Buy
Price Target: $8
Current: $2.41
Upside: n/a
Nov 19, 2021
Maintained: Buy
Price Target: $67
Current: $149.71
Upside: n/a
Mar 8, 2021
Maintained: Buy
Price Target: $7 → $6
Current: $5.12
Upside: n/a
Oct 5, 2020
Maintained: Buy
Price Target: $8
Current: $14.15
Upside: n/a
Mar 19, 2020
Downgraded: Hold
Price Target: $7 → $10
Current: $0.0001
Upside: n/a